In this respect, it is noteworthy that in clinical neuroblastoma the expression of splicing and RNA processing factor genes was seen to coincide with PRMT5, E2F1 and MYCN levels, and similarly with some of the exon skipping events in the apoptotic genes. Here, E2F1 is linked to neuroblastoma.